Heteroaryl or aryl substituted carboxylic acid or carboxamide derivatives optionally substituted with a sulphonamido group

    公开(公告)号:NZ502820A

    公开(公告)日:2002-10-25

    申请号:NZ50282098

    申请日:1998-08-27

    Applicant: VERTEX PHARMA

    Abstract: A compound of the formula (I) and its derivatives can be used, either alone or in conjunction with a neurotrophic factor, such as nerve growth factor, to promote repair of neuronal damage caused by disease or physical trauma, where: A and B are H, Ar, or optionally substituted alkyl, alkenyl or alkynyl, where any one of the CH2 groups of alkyl, alkenyl or alkynyl chains in A or B is optionally replaced by O, S, S(O), S(O)2 OR N(R); Ar is defined in the specification; n is 0 - 2; X is N, O or C(R), when X is N or C(R), Y is H, Ar, or optionally substituted alkyl, alkenyl or alkynyl and when X is O, Y is a lone pair of electrons; R is H, alkyl, alkenyl or alkynyl; K is optionally substituted alkyl, alkenyl or alkynyl, or cyclohexylmethyl, where any one of the CH2 groups of alkyl, alkenyl or alkynyl chains in K is optionally replaced by O, S, S(O), S(O)2 OR N(R); J is H, optionally substituted alkyl, alkenyl or alkynyl, or cyclohexylmethyl D is Ar, or optionally substituted alkyl, alkenyl or alkynyl, or cyclohexylmethyl, where any one of the CH2 groups of alkyl chains in D other than the one that is directly bound to the S(O)2 is optionally replaced by O, S, S(O), S(O)2 OR N(R); and that the compound of formula (I) is not (S)-(2-(5-(dimethylamino)-1-naphthalenesulfanilamido)-3-phenyl)carboxylic acid, 1-(pyridin-4-yl) propyl ester or (S)-(p-toluenesulfanilamido)-3-phenyl-N-(2-pyridin-2-yl)methyl)propionamide; and provided that (i) when X is N, n is 0 and Y is H or alkyl; or (ii) when X is O n is 0; or (iii) when X is C-H, n is 0 and Y is H; then D is Ar, or optionally substituted alkyl, alkenyl or alkynyl, or cyclohexylmethyl, where any one of the CH2 groups of alkyl chains in D other than the one that is directly bound to the S(O)2 is optionally replaced by O, S, S(O), S(O)2 OR N(R).

Patent Agency Ranking